Enochian Biosciences Inc. (ENOB)
NASDAQ: ENOB
· Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM
Enochian Biosciences Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | 42,826.8B | 42,826.8B | 38,556.7B | -128.96M | -42,827B | -42,827B | -38,556.9B | -113.83M | -113.8M | -115.77M | -116.08M | -32.05M | -31.07M | -28.05M | -23.4M | -12.05M | -12.83M | -12.34M |
Interest Income | 8.63K | 8.63K | 8.63K | n/a | -8.63K | -5.62K | n/a | 107.79K | 115.08K | 120.55K | 122.04K | 27.26K | 21.4K | 15.98K | 13.18K | 13.78K | 24.71K | 40.05K |
Pretax Income | 44,213B | 44,213B | 39,683.9B | -135.31M | -44,213.2B | -44,213.2B | -39,684.1B | -106.72M | -108.6M | -110.72M | -113.43M | -40.56M | -38.39M | -34.74M | -26.85M | -13.58M | -11.06M | -9.85M |
Net Income | 44,213B | 44,213B | 39,683.9B | 387.01B | -44,213.2B | -44,213.2B | -39,684.1B | -387.34B | -194.39M | -196.43M | -198.72M | -40.56M | -38.39M | -34.74M | -26.72M | -13.46M | -10.94M | -9.73M |
Selling & General & Admin | 18,934.6B | 18,934.6B | 22,551B | 37,869.1B | 18,934.6B | 18,934.6B | 15,318.2B | 15.53M | 14.52M | 14.66M | 14.57M | 13.49M | 12.64M | 10.43M | 7.74M | 7.16M | 6.7M | 7M |
Research & Development | 4,785.7B | 4,785.7B | 5,406.2B | 9,571.4B | 4,785.7B | 4,785.7B | 4,165.2B | 4.94M | 5.91M | 7.73M | 8.13M | 18.44M | 18.3M | 17.49M | 15.54M | 4.77M | 6M | 5.22M |
Other Expenses | 47.68M | 90.32M | 33.25B | 19,106.7B | 19,106.7B | 19,106.7B | 19,073.5B | 113.82K | 85.58K | 56.73K | 28.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 23,720.3B | 23,720.4B | 27,990.4B | 66,547.3B | 42,827B | 42,827B | 38,556.9B | 20.58M | 20.55M | 22.51M | 22.83M | 32.05M | 31.07M | 28.05M | 23.4M | 12.05M | 12.83M | 12.34M |
Interest Expense | 855.33B | 855.33B | 580.34B | -1.58M | -855.33B | -855.33B | -580.34B | 547.85K | 378.2K | 378.69K | 372.84K | 375.85K | 376.99K | 377.03K | 379.61K | 374.34K | 290.02K | 196.59K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23,720.3B | 23,720.3B | 27,990.3B | 66,547.2B | 42,827B | 42,827B | 38,556.9B | 20.58M | 20.55M | 22.51M | 22.83M | 32.05M | 31.07M | 28.05M | 23.4M | 12.05M | 12.83M | 12.34M |
Income Tax Expense | 509.06K | 509.06K | 509.06K | -387.15B | -509K | -419.12K | 64.00 | 387.23B | 85.79M | 85.7M | 85.29M | -441 | -1.29K | -2.45K | -125.48K | -125.01K | -124.16K | -123K |
Shares Outstanding (Basic) | 162.34M | 161.82M | 156.57M | 96.25M | 109.25M | 65.85M | 56.27M | 55.98M | 55.51M | 55.1M | 52.53M | 52.64M | 52.32M | 52.22M | 49.69M | 46.78M | 46.66M | 46.6M |
Shares Outstanding (Diluted) | 163.93M | 161.82M | 156.57M | 96.25M | 109.25M | 65.85M | 56.27M | 55.98M | 55.51M | 55.1M | 52.53M | 52.64M | 52.32M | 52.22M | 49.69M | 46.78M | 46.66M | 46.6M |
EPS (Basic) | 459.36K | 459.36K | 459.36K | -239.06K | -705.34K | -705.34K | -705.34K | -6.92K | -3.69 | -3.74 | -3.79 | -0.8 | -0.77 | -0.7 | -0.55 | -0.29 | -0.24 | -0.21 |
EPS (Diluted) | 459.36K | 459.36K | 459.36K | -239.06K | -705.34K | -705.34K | -705.34K | -6.92K | -3.69 | -3.74 | -3.79 | -0.8 | -0.77 | -0.7 | -0.55 | -0.29 | -0.24 | -0.21 |
EBITDA | 44,921.7B | 44,921.6B | 44,921.6B | 4,770.8B | -40,150.9B | -40,150.9B | -40,150.9B | -20.36M | -20.32M | -22.28M | -25.59M | -38.75M | -38.85M | -35.56M | -27.67M | -13.77M | -13.45M | -13.23M |
EBIT | -62.05M | -109.27M | -4,804.2B | -45,068.5B | -45,068.5B | -45,068.5B | -40,264.4B | -106.17M | -108.22M | -110.34M | -113.06M | -40.18M | -38.01M | -34.36M | -26.47M | -13.21M | 2.3B | 2.3B |
Depreciation & Amortization | -146.66B | -146.66B | -113.5B | 124.31K | 146.66B | 146.66B | 113.5B | 93.47M | 93.47M | 93.48M | 93.48M | 126.75K | 125.86K | 124.81K | 123.53K | 121.71K | 119.08K | 117.56K |